Cargando…
Global Reduction of H3K4me3 Improves Chemotherapeutic Efficacy for Pediatric Ependymomas()
BACKGROUND: Ependymomas (EPNs) are the third most common brain tumor in children. These tumors are resistant to available chemotherapeutic treatments, therefore new effective targeted therapeutics must be identified. Increasing evidence shows epigenetic alterations including histone posttranslationa...
Autores principales: | Lewis, Rebecca, Li, Yuping D, Hoffman, Lindsey, Hashizume, Rintaro, Gravohac, Gordan, Rice, Gavin, Wadhwani, Nitin R, Jie, Chunfa, Pundy, Tatiana, Mania-Farnell, Barbara, Mayanil, Chandra S, Soares, Marcelo B, Lei, Ting, James, Charles D, Foreman, Nicolas K, Tomita, Tadanori, Xi, Guifa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477190/ https://www.ncbi.nlm.nih.gov/pubmed/31005631 http://dx.doi.org/10.1016/j.neo.2019.03.012 |
Ejemplares similares
-
Targeting CD133 improves chemotherapeutic efficacy of recurrent pediatric pilocytic astrocytoma following prolonged chemotherapy
por: Xi, Guifa, et al.
Publicado: (2017) -
WDR82-Mediated H3K4me3 Is Associated with Tumor Proliferation and Therapeutic Efficacy in Pediatric High-Grade Gliomas
por: Wadhwani, Nitin, et al.
Publicado: (2023) -
Therapeutic Potential for Bone Morphogenetic Protein 4 in Human Malignant Glioma
por: Xi, Guifa, et al.
Publicado: (2017) -
Chiari type I malformation of infants and toddlers
por: Grahovac, Gordan, et al.
Publicado: (2018) -
Nuclear localization of folate receptor alpha: a new role as a transcription factor
por: Boshnjaku, Vanda, et al.
Publicado: (2012)